Key facts
- Mediphone’s last known valuation is $32.4M (Jun 2022).
- It has raised $11.3M; the latest was Later Stage VC in Nov 2025.
- Notable investors include Sony Innovation Fund, UTokyo Innovation Platform Company, Aflac Ventures Japan, Fast Track Initiative, Kepple (Media and Information Services (B2B)) — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Mediphone
- ·The full record, as it builds
Funding rounds
No funding rounds for Mediphone are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mediphone
Provider of medical interpreter services intended to eliminate language barriers in medical care. The company's services include deploying a medical translation application, hospitalization guidance, and dispatch of a medical interpreter to advanced treatment and medical checkups, enabling clients to access healthcare services without facing language barrier issues in regions of their choice in a convenient manner.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2018
- Employees
- 71
- Website
- mediphone.co.jp/
- Ownership
- Privately Held (backing)
Mediphone doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mediphone shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mediphone in its N-PORT filings yet. We sweep new filings monthly.